His biological markers looked younger at 45 than at 35. Here's the mechanism.
Epithalon is the most extensively researched anti-aging peptide in existence — 40+ years of studies from the St. Petersburg Institute of Bioregulation. It activates telomerase, the enzyme that lengthens your telomeres — the protective chromosome caps that shorten with every cell division and mark your biological age. It also restores your pineal gland's melatonin rhythm (which declines with age), normalizes cortisol, and has shown oncostatic effects in aged tissue models. A 25-year human follow-up showed 28% lower mortality in the treated group. Not a supplement. Not a vitamin. A chronobiological signal.
Epithalon
Epithalamin / Epithalon (Ala-Glu-Asp-Gly)
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland hormone epithalamin. It has the most extensive anti-aging research base of any peptide — 40+ years of studies by the St. Petersburg Institute of Bioregulation. Key mechanisms: telomere elongation, telomerase activation, melatonin normalisation, and cancer suppression in aged tissue models.
Technical details
- CAS number
- 307297-39-8
- Molecular formula
- C14H22N4O9
MECHANISM OF ACTION
Epithalon activates telomerase enzyme in somatic cells, enabling elongation of telomeres — the protective caps on chromosomes that shorten with each cell division and mark biological aging. It also restores circadian melatonin secretion from the pineal gland (which declines with age), modulates the hypothalamic-pituitary axis, reduces cortisol, and demonstrates oncostatic (cancer-suppressing) properties in aged rodent mammary and colon tissue models. The net effect across 40 years of research is consistent extension of lifespan and healthspan in rodent models.
RESEARCH HIGHLIGHTS
Telomerase activation and telomere elongation in human somatic cells — first peptide to demonstrate this in vitro
Extension of mean and maximum lifespan in elderly Drosophila and rodent models — most consistent longevity data of any peptide
Normalises melatonin production in elderly women — restores circadian rhythm and improves sleep architecture
Oncostatic effect — significantly reduces incidence of mammary and bowel tumours in aged rodents vs control
25-year follow-up study of patients who received Epithalamin: 28% lower mortality vs matched controls
RESEARCH PROTOCOLS
For laboratory use only. Not medical advice.
Classic Khavinson protocol — 10-day burst, twice per year. Administer in the evening to align with natural melatonin rhythm. Most researchers report improved sleep quality within the first 3 days.
Extended burst protocol — 20 days, 3x per year. Evening administration. Used in the St. Petersburg longevity studies.
Higher dose for accelerated telomere support. Pairs with GHK-Cu for comprehensive anti-aging synergy addressing both telomere maintenance and collagen/tissue remodelling.
PAIRS WELL WITH
ORDER
SAFETY & CONTRAINDICATIONS
- Active malignancy (telomerase activation — absolute contraindication)
- Personal or strong family history of cancer (relative contraindication — assess risk/benefit)
- Pregnancy or breastfeeding
- Known hypersensitivity to pineal-derived peptides
Excellent long-term tolerability in 40+ years of clinical research. Reported effects: improved sleep quality and dream vividness (common and expected), mild fatigue in first 3 days (normalises), slight morning grogginess at higher doses. No serious adverse events recorded in any published study.
For research and laboratory use only. Not intended for human consumption. Not for diagnostic or therapeutic purposes.